Provided by Tiger Trade Technology Pte. Ltd.

AKESO

109.100
-1.500-1.36%
Volume:3.43M
Turnover:371.80M
Market Cap:100.48B
PE:-88.50
High:110.400
Open:110.100
Low:106.800
Close:110.600
52wk High:156.000
52wk Low:80.200
Shares:921.00M
HK Float Shares:921.00M
Volume Ratio:0.29
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.233
ROE:-13.59%
ROA:-4.57%
PB:10.11
PE(LYR):-88.50
PS:24.88

Loading ...

Akeso Leaves Share Count Unchanged in September 2026; 10.81 Million Options Outstanding

Bulletin Express
·
Yesterday

Movement Alert|AKESO Falls 3.16% in Regular Trading, Biotech Sector Selloff Dragging Down Innovative Drug Stocks

Market Focus
·
Yesterday

Hong Kong Stock Movers: Innovative Drug Stocks Extend Gains as BofA Points to Three Major Recent Partnerships Strengthening Sector Momentum and ESMO Set to Bring Dense Catalysts

Stock News
·
Oct 06

Movement Alert|AKESO Rises 3.3% in Regular Trading, Ivonescimab Global Combination Therapy Advances

Market Focus
·
Oct 06

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Oct 02

Akeso (SEHK:9926) Could Be 31% Undervalued As Phase III Trial Hits Key Goals

Simply Wall St.
·
Oct 02

Movement Alert|AKESO Falls 3.59% in Regular Trading, Biotech Sector Broadly Weak as Post-Rally Profit-Taking Continues

Market Focus
·
Oct 02

Major Drugmakers Turn to China for Licensing Deals

Reuters
·
Sep 30

Should Phase III Cancer Trial Win Require Action From Akeso Stock Investors?

Simply Wall St.
·
Sep 30

Daiwa: Akeso's Global Partner Summit Secures AstraZeneca Investment, Boosting Ivonescimab's Global Peak Sales Potential

Stock News
·
Sep 30

Nomura Assigns HK$138.29 Target Price and "Buy" Rating to Akeso

Stock News
·
Sep 30

Movement Alert|AKESO Falls 3.86% in Regular Trading, Profit-Taking After Previous Session Surge of Over 15% on AstraZeneca-Summit Deal

Market Focus
·
Sep 30

Hong Kong Stock Connect Innovative Drug Sector Defies Market Downturn as Top Pharmaceutical Firm Enters with US$2 Billion, Akeso Surges 15.54%, Hengrui Pharma Secures US$2.6 Billion BD Deal

Deep News
·
Sep 29

Akeso, Inc. (09926): Yu Xia Acquires Shares, Long Position Rises to 25.0%

HK Disclosure
·
Sep 29

China A-Share Indices Reverse Early Gains as Real Estate Stocks Surge, Vanke Hits Limit Up, Biotech Rallies, Hang Seng Tech Falls Over 1%, New Energy Vehicle Shares Decline

Deep News
·
Sep 29

Hong Kong Stocks Open: Hang Seng Index Turns Lower After Flat Start; Pharma Shares Defy Trend as AKESO Surges Nearly 10%

Stock News
·
Sep 29

AKESO Jumps as AstraZeneca's $2B Strategic Investment in Summit Provides Top-Tier Pharma Endorsement for Ivonescimab

Market Focus
·
Sep 29

Akeso Biotech Jumps Over 8% at Open as AstraZeneca Makes US$2 Billion Strategic Investment in Summit, Ivonescimab Gains Backing from Top Pharma

Stock News
·
Sep 29

AstraZeneca's $2 Billion Stake in Summit Signals Confidence in Akeso's Ivonescimab

Deep News
·
Sep 29

Akeso: Zhongmin Maxwell Wang Passively Diluted, Long Position Falls to 4.67%

HK Disclosure
·
Sep 28